May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
The Effectiveness of Triamcinolone Acetate Intravitreal Injection in Retinal Vascular Diseases
Author Affiliations & Notes
  • J.C. Chen
    Ophthalmology, McGill University, Montreal, PQ, Canada
  • I.J. Galic
    Ophthalmology, McGill University, Montreal, PQ, Canada
  • Footnotes
    Commercial Relationships  J.C. Chen, None; I.J. Galic, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4046. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.C. Chen, I.J. Galic; The Effectiveness of Triamcinolone Acetate Intravitreal Injection in Retinal Vascular Diseases . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4046.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:To evaluate the effectiveness of intravitreal triamcinolone for the treatment of macular edema associated with different retinal vascular conditions. Methods:A retrospective chart review of patients presenting with macular edema who have been treated with intravitreal triamcinolone over a two–year period. Pre–treatment and post–treatment visual acuity, optical coherence tomography (OCT) findings, fluorescein angiogram and intraocular pressure were analyzed. Results: 160 patients were reviewed. 89 patients were included in the study and had the following diagnoses; diabetic retinopathy, central vein occlusion, branch vein occlusion and post–operative cystoid macular edema (CME). Visual improvement was seen in 52% of patients had visual acuity improvement (diabetic retinopathy 51%, central vein occlusion 42%, branch vein occlusion 50%, post–operative CME 55%). Anatomic improvement, as documented by OCT, occurred in the majority regardless of functional outcome. Effectiveness of treatment decreases with chronicity of disease. Complications included elevated intraocular pressure in 47% of patients. No endophthalmitis was encountered in this group. Conclusions: Intravitreal triamcinolone is an effective treatment for macular edema of various causes. Early intervention prior to structural damage is recommended.

Keywords: macula/fovea • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled • vascular occlusion/vascular occlusive disease 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.